市場調査レポート

商品コード

1786787

非小細胞肺がん（NSCLC）の世界市場、規模、シェア、動向、産業分析レポート：タイプ別、治療別、流通チャネル別、地域別 - 市場予測、2025年～2034年

Non-Small Cell Lung Cancer Market Size, Share, Trends, & Industry Analysis Report By Type, By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Distribution Channel, and By Region - Market Forecast, 2025-2034

出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 631,805円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 780,465円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 929,125円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.66円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、非小細胞肺がん（NSCLC）の市場規模は2034年までに1,298億8,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

非小細胞肺がん（NSCLC）は世界の肺がん症例の大部分を占め、精密腫瘍学の進歩を牽引しています。バイオマーカー検査、標的療法、免疫療法の利用が増加し、治療アプローチが再構築されつつある一方、リキッドバイオプシーや変異特異的薬剤の革新が早期診断と転帰の改善を可能にしています。

市場成長の主な原動力は、NSCLCの世界の罹患率の上昇、標的療法と免疫療法の採用の増加、個別化治療計画をサポートするコンパニオン診断薬の利用可能性の拡大です。

非小細胞肺がん（NSCLC）市場レポートハイライト

タイプ別では、高い罹患率と標的治療オプションへの強い反応性により、2024年の市場シェアは腺がんセグメントが優位を占めました。

治療別では、EGFR、ALK、KRAS阻害剤の広範な臨床使用に支えられ、標的療法セグメントが2024年の市場を独占しました。

流通チャネル別では、先進的ながん治療薬への集中的なアクセスと臨床監視により、病院薬局セグメントが2024年の市場を独占しました。

2024年の世界の非小細胞肺がん（NSCLC）市場では、分子診断法の早期導入と新規治療に対する規制当局の支援により、北米が大半のシェアを占めました。

アジア太平洋地域は、がん罹患率の上昇、医療アクセスの拡大、腫瘍学研究への投資の増加により、予測期間中に最も速いCAGRで成長すると予測されています。

世界の主要市場企業：Roche Holding AG、AstraZeneca PLC、Merck & Co.など

市場スナップショット
非小細胞肺がん（NSCLC）市場力学
- 促進要因と機会
  - 世界中で急増する非小細胞肺がん（NSCLC）症例
  - 液体生検とマルチプレックス検査プラットフォームの臨床導入の増加
- 抑制要因と課題
  - 高度な診断ツールに伴う高コスト
PESTEL分析
非小細胞肺がん（NSCLC）市場動向
バリューチェーン分析

第5章世界の非小細胞肺がん（NSCLC）市場：タイプ別

主な調査結果
イントロダクション
扁平上皮がん
大細胞がん
腺がん
その他

第6章世界の非小細胞肺がん（NSCLC）市場：治療別

主な調査結果
イントロダクション
化学療法
標的療法
免疫療法
その他

第7章世界の非小細胞肺がん（NSCLC）市場：流通チャネル別

主な調査結果
イントロダクション
病院薬局
ドラッグストア・小売薬局
オンライン薬局

第8章世界の非小細胞肺がん（NSCLC）市場：地域別

主な調査結果
イントロダクション
- 非小細胞肺がん（NSCLC）市場評価：地域別、2020年～2034年
北米
- 北米：タイプ別、2020～2034年
- 北米：治療別、2020～2034年
- 北米：流通チャネル別、2020～2034年
- 米国
- カナダ
欧州
- 欧州：タイプ別、2020～2034年
- 欧州：治療別、2020～2034年
- 欧州：流通チャネル別、2020～2034年
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋地域
- アジア太平洋地域：タイプ別、2020～2034年
- アジア太平洋地域：治療別、2020～2034年
- アジア太平洋地域：流通チャネル別、2020～2034年
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋地域
中東・アフリカ
- 中東・アフリカ：タイプ別、2020～2034年
- 中東・アフリカ：治療別、2020～2034年
- 中東・アフリカ：流通チャネル別、2020～2034年
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
ラテンアメリカ
- ラテンアメリカ：タイプ別、2020-2034年
- ラテンアメリカ：治療別、2020-2034年
- ラテンアメリカ：流通チャネル別、2020～2034年
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第9章競合情勢

拡大と買収の分析
- 拡大
- 買収
提携/協業/合意/公開

第10章企業プロファイル

Amgen Inc.
AstraZeneca PLC
Beigene Ltd.
Bristol-Myers Squibb Company
Eli Lilly And Company
Exelixis Inc.
Johnson & Johnson
Merck & Co., Inc.
Mirati Therapeutics Inc.
Novartis AG
Pfizer Inc.
Roche Holding AG

図表

List of Tables:

Table 1 Global Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 2 Global Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 3 Global Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 4 North America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 5 North America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 6 North America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 7 U.S.: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 8 U.S.: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 9 U.S.: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 10 Canada: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 11 Canada: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 12 Canada: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 13 Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 14 Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 15 Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 16 UK: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 17 UK: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 18 UK: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 19 France: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 20 France: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 21 France: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 22 Germany: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 23 Germany: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 24 Germany: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 25 Italy: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 26 Italy: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 27 Italy: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 28 Spain: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 29 Spain: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 30 Spain: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 31 Netherlands: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 32 Netherlands: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 33 Netherlands: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 34 Russia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 35 Russia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 36 Russia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 37 Rest of Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 38 Rest of Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 39 Rest of Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 40 Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 41 Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 42 Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 43 China: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 44 China: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 45 China: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 46 India: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 47 India: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 48 India: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 49 Malaysia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 50 Malaysia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 51 Malaysia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 52 Japan: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 53 Japan: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 54 Japan: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 55 Indonesia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 56 Indonesia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 57 Indonesia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 58 South Korea: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 59 South Korea: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 60 South Korea: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 61 Australia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 62 Australia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 63 Australia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 64 Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 65 Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 66 Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 67 Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 68 Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 69 Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 70 Saudi Arabia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 71 Saudi Arabia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 72 Saudi Arabia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 73 UAE: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 74 UAE: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 75 UAE: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 76 Israel: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 77 Israel: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 78 Israel: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 79 South Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 80 South Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 81 South Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 82 Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 83 Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 84 Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 85 Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 86 Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 87 Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 88 Mexico: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 89 Mexico: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 90 Mexico: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 91 Brazil: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 92 Brazil: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 93 Brazil: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 94 Argentina: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 95 Argentina: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 96 Argentina: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
Table 97 Rest of Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
Table 98 Rest of Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
Table 99 Rest of Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Non-Small Cell Lung Cancer Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Type
Figure 7. Global Non-Small Cell Lung Cancer Market, by Type, 2024 & 2034 (USD Billion)
Figure 8. Market by Treatment
Figure 9. Global Non-Small Cell Lung Cancer Market, by Treatment, 2024 & 2034 (USD Billion)
Figure 10. Market by Distribution Channel
Figure 11. Global Non-Small Cell Lung Cancer Market, by Distribution Channel, 2024 & 2034 (USD Billion)

Product Code: PM6101

The non-small cell lung cancer market size is expected to reach USD 129.88 Billion by 2034, according to a new study by Polaris Market Research. The report "Non-Small Cell Lung Cancer Market Share, Size, Trends, Industry Analysis Report: By Type, By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Distribution Channel, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Non-small cell lung cancer (NSCLC) represents the majority of global lung cancer cases and is driving advances in precision oncology. Increasing use of biomarker testing, targeted therapies, and immunotherapies is reshaping treatment approaches, while innovations in liquid biopsy and mutation-specific drugs are enabling earlier diagnosis and better outcomes.

Market growth is primarily driven by the rising global incidence of NSCLC, increasing adoption of targeted and immune-based therapies and the growing availability of companion diagnostics that support personalized treatment plans.

Non-Small Cell Lung Cancer Market Report Highlights

Based on type, the adenocarcinoma segment dominated the market share in 2024, driven by its high prevalence and strong response to targeted therapy options.

In terms of treatment, the targeted therapy segment dominated the market in 2024, supported by the broad clinical use of EGFR, ALK, and KRAS inhibitors.

Based on distribution channel, the hospital pharmacy segment dominated the market in 2024, due to centralized access to advanced oncology drugs and clinical oversight.

North America accounted for the majority share in the global non-small cell lung cancer market in 2024, driven by early adoption of molecular diagnostics and regulatory support for novel therapies.

Asia Pacific is projected to grow at the fastest CAGR during the forecast period, owing to rising cancer incidence, expanding healthcare access, and growing investment in oncology research.

A few global key market players include Roche Holding AG, AstraZeneca PLC, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Eli Lilly And Company, Novartis AG, Johnson & Johnson, Amgen Inc., Beigene Ltd., Exelixis Inc., and Mirati Therapeutics Inc.

Polaris Market Research has segmented the market report on the basis of type, treatment, distribution channel, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Squamous Cell Carcinoma

Large Cell Carcinoma

Adenocarcinoma

Other Type

By Treatment Outlook (Revenue, USD Billion, 2020-2034)

Chemotherapy

Targeted Therapy

Immunotherapy

Others

By Distribution Channel Outlook (Revenue, USD Billion, 2020-2034)

Hospital Pharmacy

Drug Store and Retail Pharmacy

Online Pharmacy

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Non-Small Cell Lung Cancer Market Insights

4.1. Non-Small Cell Lung Cancer Market - Market Snapshot
4.2. Non-Small Cell Lung Cancer Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rapidly Rising Cases of NSCLC Globally
  - 4.2.1.2. Increasing Clinical Adoption of Liquid Biopsies and Multiplexed Testing Platforms
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Costs Associated with Advanced Diagnostic Tools
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Non-Small Cell Lung Cancer Market Trends
4.6. Value Chain Analysis

5. Global Non-Small Cell Lung Cancer Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
5.3. Squamous Cell Carcinoma
- 5.3.1. Global Non-Small Cell Lung Cancer Market, by Squamous Cell Carcinoma, by Region, 2020-2034 (USD Billion)
5.4. Large Cell Carcinoma
- 5.4.1. Global Non-Small Cell Lung Cancer Market, by Large Cell Carcinoma, by Region, 2020-2034 (USD Billion)
5.5. Adenocarcinoma
- 5.5.1. Global Non-Small Cell Lung Cancer Market, by Adenocarcinoma, by Region, 2020-2034 (USD Billion)
5.6. Other Type
- 5.6.1. Global Non-Small Cell Lung Cancer Market, by Other Type, by Region, 2020-2034 (USD Billion)

6. Global Non-Small Cell Lung Cancer Market, by Treatment

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
6.3. Chemotherapy
- 6.3.1. Global Non-Small Cell Lung Cancer Market, by Chemotherapy, by Region, 2020-2034 (USD Billion)
6.4. Targeted Therapy
- 6.4.1. Global Non-Small Cell Lung Cancer Market, by Targeted Therapy, by Region, 2020-2034 (USD Billion)
6.5. Immunotherapy
- 6.5.1. Global Non-Small Cell Lung Cancer Market, by Immunotherapy, by Region, 2020-2034 (USD Billion)
6.6. Others
- 6.6.1. Global Non-Small Cell Lung Cancer Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Non-Small Cell Lung Cancer Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
7.3. Hospital Pharmacy
- 7.3.1. Global Non-Small Cell Lung Cancer Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
7.4. Drug Store and Retail Pharmacy
- 7.4.1. Global Non-Small Cell Lung Cancer Market, by Drug Store and Retail Pharmacy, by Region, 2020-2034 (USD Billion)
7.5. Online Pharmacy
- 7.5.1. Global Non-Small Cell Lung Cancer Market, by Online Pharmacy, by Region, 2020-2034 (USD Billion)

8. Global Non-Small Cell Lung Cancer Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Non-Small Cell Lung Cancer Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Non-Small Cell Lung Cancer Market - North America
- 8.3.1. North America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
- 8.3.3. North America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.4. Non-Small Cell Lung Cancer Market - U.S.
  - 8.3.4.1. U.S.: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.5. Non-Small Cell Lung Cancer Market - Canada
  - 8.3.5.1. Canada: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4. Non-Small Cell Lung Cancer Market - Europe
- 8.4.1. Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
- 8.4.3. Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.4. Non-Small Cell Lung Cancer Market - UK
  - 8.4.4.1. UK: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.5. Non-Small Cell Lung Cancer Market - France
  - 8.4.5.1. France: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.6. Non-Small Cell Lung Cancer Market - Germany
  - 8.4.6.1. Germany: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.7. Non-Small Cell Lung Cancer Market - Italy
  - 8.4.7.1. Italy: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.8. Non-Small Cell Lung Cancer Market - Spain
  - 8.4.8.1. Spain: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.9. Non-Small Cell Lung Cancer Market - Netherlands
  - 8.4.9.1. Netherlands: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.10. Non-Small Cell Lung Cancer Market - Russia
  - 8.4.10.1. Russia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.11. Non-Small Cell Lung Cancer Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5. Non-Small Cell Lung Cancer Market - Asia Pacific
- 8.5.1. Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.4. Non-Small Cell Lung Cancer Market - China
  - 8.5.4.1. China: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.5. Non-Small Cell Lung Cancer Market - India
  - 8.5.5.1. India: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.6. Non-Small Cell Lung Cancer Market - Malaysia
  - 8.5.6.1. Malaysia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.7. Non-Small Cell Lung Cancer Market - Japan
  - 8.5.7.1. Japan: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.8. Non-Small Cell Lung Cancer Market - Indonesia
  - 8.5.8.1. Indonesia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.9. Non-Small Cell Lung Cancer Market - South Korea
  - 8.5.9.1. South Korea: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.10. Non-Small Cell Lung Cancer Market - Australia
  - 8.5.10.1. Australia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.11. Non-Small Cell Lung Cancer Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6. Non-Small Cell Lung Cancer Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.4. Non-Small Cell Lung Cancer Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.5. Non-Small Cell Lung Cancer Market - UAE
  - 8.6.5.1. UAE: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.6. Non-Small Cell Lung Cancer Market - Israel
  - 8.6.6.1. Israel: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.7. Non-Small Cell Lung Cancer Market - South Africa
  - 8.6.7.1. South Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.8. Non-Small Cell Lung Cancer Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7. Non-Small Cell Lung Cancer Market - Latin America
- 8.7.1. Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.4. Non-Small Cell Lung Cancer Market - Mexico
  - 8.7.4.1. Mexico: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.5. Non-Small Cell Lung Cancer Market - Brazil
  - 8.7.5.1. Brazil: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.6. Non-Small Cell Lung Cancer Market - Argentina
  - 8.7.6.1. Argentina: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.7. Non-Small Cell Lung Cancer Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Non-Small Cell Lung Cancer Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Non-Small Cell Lung Cancer Market, by Treatment, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Non-Small Cell Lung Cancer Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Amgen Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. AstraZeneca PLC
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Beigene Ltd.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Bristol-Myers Squibb Company
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Eli Lilly And Company
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Exelixis Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Johnson & Johnson
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Merck & Co., Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Mirati Therapeutics Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Novartis AG
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Pfizer Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Roche Holding AG
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development

非小細胞肺がん（NSCLC）の世界市場、規模、シェア、動向、産業分析レポート：タイプ別、治療別、流通チャネル別、地域別 - 市場予測、2025年～2034年

Non-Small Cell Lung Cancer Market Size, Share, Trends, & Industry Analysis Report By Type, By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Distribution Channel, and By Region - Market Forecast, 2025-2034

非小細胞肺がん（NSCLC）市場レポートハイライト

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の非小細胞肺がん（NSCLC）市場の洞察

第5章世界の非小細胞肺がん（NSCLC）市場：タイプ別

第6章世界の非小細胞肺がん（NSCLC）市場：治療別

第7章世界の非小細胞肺がん（NSCLC）市場：流通チャネル別

第8章世界の非小細胞肺がん（NSCLC）市場：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables:

List of Figures:

Non-Small Cell Lung Cancer Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Non-Small Cell Lung Cancer Market Insights

5. Global Non-Small Cell Lung Cancer Market, by Type

6. Global Non-Small Cell Lung Cancer Market, by Treatment

7. Global Non-Small Cell Lung Cancer Market, by Distribution Channel

8. Global Non-Small Cell Lung Cancer Market, by Geography

9. Competitive Landscape

10. Company Profiles

非小細胞肺がん（NSCLC）の世界市場、規模、シェア、動向、産業分析レポート：タイプ別、治療別、流通チャネル別、地域別 - 市場予測、2025年～2034年

Non-Small Cell Lung Cancer Market Size, Share, Trends, & Industry Analysis Report By Type, By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Distribution Channel, and By Region - Market Forecast, 2025-2034

非小細胞肺がん（NSCLC）市場レポートハイライト

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の非小細胞肺がん（NSCLC）市場の洞察

第5章 世界の非小細胞肺がん（NSCLC）市場：タイプ別

第6章 世界の非小細胞肺がん（NSCLC）市場：治療別

第7章 世界の非小細胞肺がん（NSCLC）市場：流通チャネル別

第8章 世界の非小細胞肺がん（NSCLC）市場：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables:

List of Figures:

Non-Small Cell Lung Cancer Market Report Highlights

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Non-Small Cell Lung Cancer Market Insights

5. Global Non-Small Cell Lung Cancer Market, by Type

6. Global Non-Small Cell Lung Cancer Market, by Treatment

7. Global Non-Small Cell Lung Cancer Market, by Distribution Channel

8. Global Non-Small Cell Lung Cancer Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章世界の非小細胞肺がん（NSCLC）市場の洞察

第5章世界の非小細胞肺がん（NSCLC）市場：タイプ別

第6章世界の非小細胞肺がん（NSCLC）市場：治療別

第7章世界の非小細胞肺がん（NSCLC）市場：流通チャネル別

第8章世界の非小細胞肺がん（NSCLC）市場：地域別

第9章競合情勢

第10章企業プロファイル